Granahan Investment Management - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 161 filers reported holding ARCUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.5%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$3,511,002
-45.1%
195,599
-37.9%
0.12%
-36.5%
Q2 2023$6,394,319
-39.2%
314,836
-45.4%
0.20%
-38.4%
Q1 2023$10,519,884
+23.9%
576,748
+40.5%
0.32%
+23.1%
Q4 2022$8,488,726
-5.5%
410,480
+19.6%
0.26%
-11.3%
Q3 2022$8,982,000
+41.6%
343,335
+37.1%
0.29%
+35.0%
Q2 2022$6,345,000
-11.1%
250,385
+10.8%
0.22%
+22.6%
Q1 2022$7,134,000
+28.3%
226,050
+64.5%
0.18%
+55.3%
Q4 2021$5,560,000
+52.1%
137,387
+31.0%
0.11%
+65.2%
Q3 2021$3,656,000104,8480.07%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q1 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$33,337,75217.74%
Octagon Capital Advisors LP 2,482,700$51,342,2367.99%
Decheng Capital Management III (Cayman), LLC 869,790$17,987,2576.73%
BVF INC/IL 2,303,520$47,636,7942.01%
PFM Health Sciences, LP 2,703,287$55,903,9752.00%
Boxer Capital, LLC 1,432,200$29,617,8961.56%
Ikarian Capital, LLC 283,100$5,854,5081.41%
SECTORAL ASSET MANAGEMENT INC 238,482$4,931,8080.95%
HighVista Strategies LLC 71,650$1,481,7220.88%
DAFNA Capital Management LLC 142,217$2,941,0480.83%
View complete list of ARCUS BIOSCIENCES INC shareholders